News

Click here to answer this week's skin cancer poll.

Additionally, investigators found that several patients in the review had rosacea induced or exacerbated by the use of topical corticosteroids on the face.

In this week’s Pointers With Portela, the 208SkinDoc explains the hidden risks associated with hair transplants.

The approved indication makes Wezlana the first approved interchangeable biosimilar to Stelara.

ChatGPT shows promise in dermatology but needs improvement in accuracy and conciseness for reliable clinical use, according to a study evaluating its performance in actinic keratosis management.

A comparative study revealed that color constancy algorithms reduce the variability of dermoscopy image quality, leading to positive outcomes for practitioners.

Learn more about the in-depth topics covered in the October 2023 print issue of Dermatology Times.

Secukinumab is currently the only IL-17A inhibitor approved for the condition.

From reducing age spots to nurturing the lip microbiome and supporting sensitive skin, 3 studies presented at the 2023 Integrative Dermatology Symposium highlighted the transformative potential of botanicals in skincare.

A new AI platform empowers health care practitioners in numerous specialties to make informed decisions and provide high-quality care to patients with scabies.

If you weren’t able to attend the 2023 Society of Dermatology Physicians Fall Conference or want to review our latest coverage and interviews, our full recap has you covered.

Click here to answer today's poll.

Review the full list of eczema resources for your patients shared during National Eczema Awareness Month.

Catch up on coverage from the fourth and final day of the 2023 SDPA Fall Dermatology Conference.

Allison Arthur, MD, discussed the importance of tailoring a treatment plan for adult women with acne vulgaris that best suits their lifestyle and current needs.

Mark Lebwohl, MD, spoke with Dermatology Times about his talk on IL-17 inhibitors.

Ted Rosen, MD, presented a session comprehensively discussing common dermatoses characterized by itch and pruritus.

The study was presented in a poster at the 2023 SDPA Fall Conference in Nashville, TN.

Leah Howard, JD, of the National Psoriasis Foundation, discusses the importance of advocacy in psoriasis, the role of mental health in chronic skin conditions, and the role of support organizations in advocating for awareness and health equity.

Catch up on coverage from the third day of the 2023 SDPA Fall Dermatology Conference.

Investigators said that additional, larger studies are needed to assess the safety of live attenuated vaccine administration for pediatric AD patients being treated with dupilumab.

Keep up with the latest headlines in dermatology from the past week, including an innovative skin cancer approach, the role of soy protein in clinical trials and skin health, and more.

Ami Greene, MD, discusses her beginner and intermediate SDPA fall conference sessions on dermoscopy.

Rebecca Vasquez, MD, presented a session on common, overlapping, and complex pigmented dermatoses.

Olushola Akinshemoyin Vaughn, MD, shared clinical pearls from her work in a vulvar dermatology clinic at the 2023 SDPA fall conference.

Once daily application of tapinarof cream 1% rapidly improved itch in adult patients with varying plaque psoriasis diseases severity, according to a poster presented at SDPA’s fall conference.

Lisa Swanson, MD, PhD, delves into clinical pearls from her SDPA fall conference sessions on infantile hemangiomas and challenging cases in pediatric dermatology.

Catch up on coverage from the second day of the 2023 SDPA Fall Dermatology Conference.

A poster presented at SDPA’s fall conference revealed key insights into the importance of close monitoring and preventative measures in patients with cSCC.

Douglas DiRuggiero, DMSc, PA-C, presented a comprehensive session at the SDPA fall conference on treatment selection for patients with psoriasis.